News
Latest news related to non-animal research
-
12 November 2025The UK unveils roadmap for alternative methods, Reflection on the REACH Revision 2025, The most comprehensive map of human brain cells, and more
NEWS, REPORTS & POSITION STATEMENTS 1. UK unveils its roadmap for alternative methods In the UK, animal testing in science is set to be phased out faster under a new plan to deliver on the government’s manifesto commitment, unveiled by […]
Read more -
4 November 2025Boosting the AOP Framework with AI, First-ever NAM to be formally qualified by the FDA, InnoZell’s Animal-free quality control, Alternatives to animal-derived products, and more
NEWS, REPORTS & POSITION STATEMENTS 1. NC3Rs’ DRIVER recommendations for in vitro research Research funders like Wellcome Trust and Cancer Research UK (CRUK) are now encouraging the use of the reporting system RIVER – Reporting In Vitro Experiments Responsibly, for […]
Read more -
29 October 2025NAMs for DILI, HUMAIN Award winners, STEP4NAMS Call, Machine learning to distinguish Neuropsychiatric disorders, and more
NEWS, REPORTS & POSITION STATEMENTS 1. NAMs for drug-induced liver injury (DILI): Where are we now ? The U.S. FDA’s National Center for Toxicological Research (NCTR) has published a new review : “New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are […]
Read more -
22 October 2025Alternatives to animal testing are the future, NC3Rs report on NAMs infrastructures, FDA’s CDER Inventory for NAMs, QKARs for enhanced drug toxicity prediction, and more
NEWS, REPORTS & POSITION STATEMENTS 1. Nature commentary on NAMs : Alternatives to animal testing are the future A new commentary has been published in the high impact journal Nature entitled “Alternatives to animal testing are the future — it’s time that journals, […]
Read more -
16 October 2025Japan joining the NAMs momentum, BiMMoH database launch, Charles River and Toxys new collaboration, Immune-competent lung-on-a-chip and more
NEWS, REPORTS & POSITION STATEMENTS 1. Japan has joined the NAMs momentum The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has joined the New Approach Methodology (NAMs) momentum alongside the FDA with the publication of guidelines to use them in […]
Read more
